Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHaydale Plc Regulatory News (HAYD)

Share Price Information for Haydale Plc (HAYD)

Share Price is delayed by 15 minutes
Get Live Data
0.3275    0.00 (0.00%)
Bid:
0.325
Ask:
0.33
Spread: 0.005 (1.538%)
Market Cap: £25.46m
HAYD Live PriceLast checked at - London Stock Exchange

Intraday Haydale Plc Share Chart

Result of Placing

23 Sep 2016 10:57

RNS Number : 6837K
Haydale Graphene Industries PLC
23 September 2016
 

THIS ANNOUNCEMENT IS RESTRICTED AND IT IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, JAPAN OR AUSTRALIA OR ANY OTHER STATE OR JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL

 

Haydale Graphene Industries plc

 ("Haydale" or the "Company" or the "Group")

Result of Placing

Issue of Equity

Director Subscription/Shareholding

 

Pursuant to the announcement released this morning at 7.00 a.m. (the "Placing and Acquisition Announcement"), the Company is pleased to announce that Cantor Fitzgerald Europe, on behalf of the Company, has successfully placed 1,272,437 new Ordinary Shares of 2 pence each in the Company ("Ordinary Shares") (the "Placing Shares") at a price of 160 pence per share (the "Placing"), representing a discount of approximately 6.8 per cent. to the price of 171.7 pence per Existing Ordinary Share, being the average Closing Price for the preceding 20 business days prior to this announcement, with new and existing institutional investors, raising gross proceeds of approximately £2.0 million.

Cantor Fitzgerald Europe acted as, sole bookrunner and broker in connection with the Placing. Cairn Financial Advisers LLP acted as nominated adviser to the Company.

In addition, certain of the directors and key management of the Company have agreed to subscribe for a total of 34,750 new Ordinary Shares on the same terms as the Placing (the "Subscription" and the "Subscription Shares") raising gross proceeds of £55,600.

The Placing and Subscription will utilise the Company's existing authorities to allot Ordinary Shares and therefore does not require shareholder approval.

The Directors' interests as at today and following completion of the Subscription and the Placing are as follows:

 

At the date of this Circular

On Admission

 

 

 

Name

 

Number of Existing Ordinary Shares

 

Percentage of Existing Ordinary Shares

 

Number of Subscription Shares

 

Number of Ordinary Shares

 

Percentage of Ordinary Shares*

John Knowles

149,214

0.97

6,250

155,464

0.91%

Antony Belisario

379,050

2.46

-

379,050

2.23%

Ray Gibbs

476,000

3.09

6,000

482,000

2.83%

Matt Wood

3,571

0.02

6,250

9,821

0.06%

Roger Smith

288,455

1.87

-

288,455

1.69%

Graham Eves

-

-

-

-

-

Roger Humm

28,459

0.18

6,250

34,709

0.20%

 

* assuming the issue of 312,500 Open Offer Shares and completion of the Placing, Subscription and Open Offer

 

 

Participation by certain Directors (as per the table above) and Trevor Rudderham (who has subscribed for 10,000 Subscription Shares) in the Subscription is considered a "related party transaction" under the AIM Rules. The Directors (other than Ray Gibbs, Matt Wood, John Knowles and Roger Humm) consider, having consulted with the Company's Nominated Adviser, that the terms of participation for Ray Gibbs, Matt Wood, John Knowles, Roger Humm and Trevor Rudderham in the Subscription are fair and reasonable in so far as its Shareholders are concerned.

Pursuant to the Placing and Subscription, application will be made for the 1,307,187 New Shares to be admitted to trading on AIM. Subject to the Placing Agreement not having been terminated in accordance with its terms, it is anticipated that admission of the Placing Shares and Subscription Shares will occur at 8.00 a.m. on or around 12 October 2016. The Placing Shares and the Subscription Shares will be credited as fully paid and rank pari passu with the Existing Ordinary Shares. Any Open Offer Shares subscribed for under the Open Offer are also expected to be admitted to trading on AIM on or around 12 October 2016 in accordance with the timetable set out in the Placing and Acquisition Announcement.

Other than where defined, capitalised terms used in this announcement have the meanings given to them in the Placing and Acquisition Announcement.

 

For further information, please contact:

 

Haydale Graphene Industries plc

+44 (0) 1269 842 946

John Knowles, Chairman

Ray Gibbs, Chief Executive Officer

 

Cairn Financial Advisers LLP (Nomad)

+44 (0) 20 7148 7900

Tony Rawlinson

Emma Earl

 

Cantor Fitzgerald Europe (Broker)

+44 (0) 20 7894 7000

David Foreman (Corporate Finance)

Will Goode (Corporate Finance)

David Banks (Sales)

 

Hermes Financial PR

Trevor Phillips

Chris Steele

+44 (0) 7889 153 628

+44 (0) 7979 604 687

 

 

Note to editors:

 

About Haydale Graphene Industries plc

Haydale has developed a patented scalable plasma process to functionalise graphene and other nanomaterials. This enabling technology can provide Haydale with a rapid and highly cost-efficient method of supplying tailored solutions to enhance applications for both raw material suppliers and product manufacturers.

Functionalisation is carried out through a patented low-pressure plasma process that treats both mined, organic fine powder and other synthetically produced nanomaterial powders, producing high-quality few layered graphenes and graphene nanoplatelets. The process can functionalise with a range of chemical groups, with the level of functionalisation tailored to the customer's needs. Good dispersion improves the properties and performance of the host material and ensures the final product performs as specified.

The Haydale plasma process does not use wet chemistry, nor does it damage the material being processed; rather, it can clean up any impurities inherent in the raw material. The technology is a low energy user and most importantly environmentally friendly. The Haydale process is a patented enabling technology, allowing the Group to work with a raw material producer who seeks to add value to the base product and tailor the outputs to meet the target applications of the end user.

Haydale, based in South Wales and housed in a purpose-built facility for processing and handling nanomaterials, is facilitating the application of graphenes and other nanomaterials in fields such as inks, sensors, energy storage, composites, paints and coatings.

www.haydale.com Twitter: @haydalegraphene

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon publication of this announcement, this information is now considered to be in the public domain. 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEKMGZLLFKGVZG
Date   Source Headline
21st May 20267:05 amRNSProposed Commercial Relationship
8th Apr 20265:18 pmRNSDirector/PDMR Shareholding
7th Apr 20267:00 amRNSNew Contract Signed
26th Mar 20263:39 pmRNSResult of AGM
6th Mar 20261:31 pmRNSInvestor Presentation via Investor Meet Company
2nd Mar 20267:00 amRNSStrategic Digital Infrastructure Partnership
17th Feb 20267:00 amRNSFinal Results and Post-Period Trading Update
11th Feb 20267:00 amRNSNotice of Annual Results
30th Jan 20269:45 amRNSTotal Voting Rights
22nd Jan 20264:54 pmRNSHolding(s) in Company
22nd Jan 20267:00 amRNSHolding(s) in Company
21st Jan 202612:31 pmRNSHolding(s) in Company
15th Jan 20265:01 pmRNSHolding(s) in Company
15th Jan 20262:44 pmRNSChange of Name
12th Jan 20267:00 amRNSCompletion of Acquisition
9th Jan 20266:19 pmRNSDirector/PDMR Dealings
8th Jan 20261:59 pmRNSHolding(s) in Company
8th Jan 20261:55 pmRNSHolding(s) in Company
6th Jan 20262:45 pmRNSResult of General Meeting and Total Voting Rights
22nd Dec 20252:08 pmRNSHolding(s) in Company
22nd Dec 20252:08 pmRNSHolding(s) in Company
16th Dec 202512:45 pmRNSResult of Retail Offer
15th Dec 20259:14 amRNSResult of Accelerated Bookbuild
12th Dec 20257:05 amRNSRetail Offer
12th Dec 20257:00 amRNSProposed Fundraise and Acquisition
2nd Dec 20257:00 amRNSCommercial Update
30th Oct 202510:45 amRNSExpansion of Commercial Platform
23rd Oct 20257:00 amRNSContract Wins
11th Sep 20257:00 amRNSStrategic Collaboration and Trading Update
8th Aug 20257:00 amRNSGrant of Share Options and PDMR Dealings
11th Jul 20258:21 amRNSHolding(s) in Company
30th Jun 20253:14 pmRNSHolding(s) in Company
26th Jun 20252:00 pmRNSSubscriptions, Director Dealings & Issue of Equity
12th Jun 20252:12 pmRNSTrading Update
23rd Apr 20255:22 pmRNSDirectorate Change
17th Apr 202510:46 amRNSCorrection: Haydale US Sales Process Update
17th Apr 20257:00 amRNSHaydale US Sales Process Update
2nd Apr 20257:00 amRNSHaydale Achieves CE Certification
13th Mar 20252:15 pmRNSSubscription, Director Dealings and TVR
13th Mar 20257:00 amRNSInterim Results
7th Mar 202510:18 amRNSHaydale US sales process update
10th Feb 20257:00 amRNSHaydale US placed into insolvency process
30th Dec 20245:20 pmRNSReplacement: Result of AGM
30th Dec 202412:48 pmRNSResult of AGM
23rd Dec 20247:05 amRNSDisposal of Korean Subsidiary
23rd Dec 20247:00 amRNSBusiness Review and Appointment of CEO
6th Dec 20247:00 amRNSPosting of Annual Report and Notice of AGM
4th Dec 20249:44 amRNSHolding(s) in Company
3rd Dec 20245:38 pmRNSHolding(s) in Company
2nd Dec 20247:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.